国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Human Serine/arginine-rich splicing factor 1 (SRSF1) CSB-EP021142HU 1mg/100ug/20ug
Recombinant Japanese encephalitis virus Genome polyprotein, partial CSB-EP189574Ba 1mg/100μg/20μg
Recombinant Escherichia coli DNA mismatch repair protein MutL (mutL) CSB-EP543397ENV 1mg/100μg/20μg
Recombinant Mouse Hyaluronan synthase 2 (Has2), partial CSB-EP010140MO 1mg/100μg/20μg
Recombinant Rat Type-2 angiotensin II receptor (Agtr2), partial CSB-EP001466RA 1mg/100μg/20μg
Recombinant Human Ubiquitin-like-conjugating enzyme ATG3 (ATG3) CSB-EP002288HU 1mg/100ug/20ug
Recombinant JC polyomavirus Minor capsid protein VP2 CSB-EP355948JAK 1mg/100μg/20μg
Recombinant Rat Zinc transporter ZIP13 (Slc39a13), partial CSB-EP644804RA 1mg/100μg/20μg
Recombinant Lysobacter Enzymogenes Arg-C (ler), partial CSB-EP188874Ba 1mg/100μg/20μg
Recombinant Mouse CD82 antigen (Cd82), partial CSB-EP004961MO 1mg/100μg/20μg
Recombinant human Retinol dehydrogenase 11 (RDH11), partial CSB-EP019523HU 1mg/100ug/20ug
Recombinant Human Glypican-6 (GPC6) CSB-YP009708HU 1mg/100ug/20ug
Recombinant Human Group XIIA secretory phospholipase A2 (PLA2G12A), partial CSB-YP863638HU 1mg/100ug/20ug
Recombinant Human Casein kinase II subunit alpha' (CSNK2A2), partial CSB-EP526319HU 1mg/100ug/20ug
Recombinant Human Endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3), partial CSB-EP896688HU 1mg/100ug/20ug
Recombinant Human Sorting nexin-24 (SNX24) CSB-EP022369HU 1mg/100ug/20ug
Recombinant Human Kynurenine 3-monooxygenase (KMO) CSB-EP012475HU 1mg/100ug/20ug
Recombinant Human Inactive phospholipase D5 (PLD5) CSB-EP836686HU 1mg/100ug/20ug
Recombinant Human DNA-directed RNA polymerase III subunit RPC10 (POLR3K) CSB-EP018352HU 1mg/100ug/20ug
Recombinant Human TAR DNA-binding protein 43 (TARDBP), partial CSB-EP023129HU 1mg/100ug/20ug

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>